Related Experiment Video
Updated: Jul 13, 2026

Isolation and Purification of Fungal β-Glucan as an Immunotherapy Strategy for Glioblastoma
Published on: June 2, 2023
Fatal fulminant hepatitis associated with Ganoderma lucidum (Lingzhi) mushroom powder
Harirak Wanmuang1, Juvady Leopairut, Chomsri Kositchaiwat
1Department of Pathology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Abstract:
Hepatotoxic effect related to Ganoderma lucidum (Lingzhi) mushroom powder was first described in a patient from Hong Kong in 2004. In 2005, the authors experienced a case of fatal fulminant hepatitis associated with such a preparation. Both patients had taken other therapeutic agents and traditionally boiled Lingzhi without any toxic effect. After switching to taking Lingzhi in powder form for 1-2 months, the hepatotoxic episode occurred in both patients. The toxic role of Lingzhi powder needs close monitoring in the future, especially in combination with other drugs.
Insights
Ganoderma lucidum (Lingzhi) mushroom powder has been linked to severe liver damage, including fatal hepatitis. This risk is heightened when combined with other medications, necessitating careful monitoring.
Area of Science:
- * Integrative medicine and toxicology.
- * Herbal medicine safety and adverse event reporting.
Background:
- * Ganoderma lucidum (Lingzhi) is a widely used medicinal mushroom.
- * Traditional preparations involve boiling, while modern use includes powdered forms.
Observation:
- * Two cases of severe hepatotoxicity, including fatal fulminant hepatitis, were observed.
- * Both patients had previously used boiled Lingzhi without adverse effects.
- * Hepatotoxicity occurred after 1-2 months of using Lingzhi powder, alongside other medications.
Findings:
- * Lingzhi mushroom powder was implicated as the causative agent in severe liver injury.
- * The hepatotoxic effect appeared specific to the powder form, not traditional preparations.
- * Concurrent use of other therapeutic agents may potentiate the toxicity.
Implications:
- * The powdered form of Ganoderma lucidum requires cautious use and monitoring for potential hepatotoxicity.
- * Healthcare providers should be aware of the risks associated with Lingzhi powder, especially in patients on multiple medications.
- * Further research is needed to elucidate the mechanisms of Lingzhi-induced liver injury.
Related Concept Videos
Cryptococcal Meningitis
Hepatic Encephalopathy